Co Diagnostics Stock Price on November 7, 2024
| CODX Stock | USD 0.73 0.03 3.95% |
Below is the normalized historical share price chart for Co Diagnostics extending back to July 12, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Co Diagnostics stands at 0.73, as last reported on the 21st of December, with the highest price reaching 0.78 and the lowest price hitting 0.70 during the day.
If you're considering investing in CODX Stock, it is important to understand the factors that can impact its price. Co Diagnostics retains Efficiency (Sharpe Ratio) of -0.23, which signifies that the company had a -0.23% return per unit of price deviation over the last 3 months. Co Diagnostics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Co Diagnostics' Information Ratio of (0.26), market risk adjusted performance of 1.58, and Variance of 10.27 to double-check the risk estimate we provide.
At this time, Co Diagnostics' Preferred Stock Total Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 8.8 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 44.2 M in 2024. . Price To Sales Ratio is likely to drop to 5.44 in 2024. Price Earnings Ratio is likely to drop to -1.16 in 2024. CODX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of July 2017 | 200 Day MA 1.195 | 50 Day MA 1.08 | Beta (0.85) |
CODX |
Sharpe Ratio = -0.2324
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CODX |
Estimated Market Risk
| 3.17 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.74 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Co Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Co Diagnostics by adding Co Diagnostics to a well-diversified portfolio.
Price Book 0.3654 | Enterprise Value Ebitda 0.5218 | Price Sales 3.1646 | Shares Float 30.2 M | Wall Street Target Price 1.5 |
Related Headline
Senseonics Holdings Headline on 7th of November 2024
Senseonics Holdings, Inc. Reports Third Quarter 2024 Financi... by finance.yahoo.com
GERMANTOWN, Md., Nov. 07, 2024 -- Senseonics Holdings, Inc. , a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Accomplishments Eversense 365 approved in the US as an integrated continuous glucose monitoring system for people with T
Co Diagnostics Valuation on November 7, 2024
It is possible to determine the worth of Co Diagnostics on a given historical date. On November 7, 2024 CODX was worth 1.18 at the beginning of the trading date compared to the closed value of 1.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Co Diagnostics stock. Still, in general, we apply an absolute valuation method to find Co Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Co Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Co Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 1.22 | 1.24 | 1.18 | 1.21 | 86,358 | |
11/07/2024 | 1.18 | 1.21 | 1.18 | 1.18 | 99,744 |
| 1.16 | 1.18 | 1.14 | 1.14 | 128,048 |
| Backtest Co Diagnostics | | | Co Diagnostics History | | | Co Diagnostics Valuation | Previous | Next |
Co Diagnostics Trading Date Momentum on November 7, 2024
| On November 08 2024 Co Diagnostics was traded for 1.14 at the closing time. The top price for the day was 1.18 and the lowest listed price was 1.14 . The trading volume for the day was 128 K. The trading history from November 8, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.39% . The overall trading delta against the current closing price is 11.02% . |
Co Diagnostics Fundamentals Correlations and Trends
By evaluating Co Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CODX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Co Diagnostics Stock history
Co Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CODX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Co Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Co Diagnostics stock prices may prove useful in developing a viable investing in Co Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.3 M | 22.2 M | |
| Net Loss | -16.4 M | -15.6 M |
Co Diagnostics Quarterly Net Working Capital |
|
Co Diagnostics Stock Technical Analysis
Co Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Co Diagnostics Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Co Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Co Diagnostics December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Co Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Co Diagnostics shares will generate the highest return on investment. By undertsting and applying Co Diagnostics stock market strength indicators, traders can identify Co Diagnostics entry and exit signals to maximize returns
Co Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Co Diagnostics' price direction in advance. Along with the technical and fundamental analysis of CODX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CODX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | 1.57 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.